Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M511560200 on December 16, 2005

J. Biol. Chem., Vol. 281, Issue 9, 5373-5382, March 3, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/9/5373    most recent
M511560200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hanrott, K.
Right arrow Articles by Wonnacott, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hanrott, K.
Right arrow Articles by Wonnacott, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

6-Hydroxydopamine-induced Apoptosis Is Mediated via Extracellular Auto-oxidation and Caspase 3-dependent Activation of Protein Kinase C{delta}*

Katharine Hanrott{ddagger}, Louise Gudmunsen{ddagger}, Michael J. O'Neill§, and Susan Wonnacott{ddagger}1

From the {ddagger}Department of Biology & Biochemistry, University of Bath, 4 South, Claverton Down, Bath BA2 7AY and §Eli Lilly & Co. Ltd., Windlesham, Surrey GU20 6PH, United Kingdom

6-Hydroxydopamine is a neurotoxin commonly used to lesion dopaminergic pathways and generate experimental models for Parkinson disease, however, the cellular mechanism of 6-hydroxydopamine-induced neurodegeneration is not well defined. In this study we have explored how 6-hydroxydopamine neurotoxicity is initiated. We have also investigated downstream signaling pathways activated in response to 6-hydroxydopamine, using a neuronal-like, catecholaminergic cell line (PC12 cells) as an in vitro model system. We have shown that 6-hydroxydopamine neurotoxicity is initiated via extracellular auto-oxidation and the induction of oxidative stress from the oxidative products generated. Neurotoxicity is completely attenuated by preincubation with catalase, suggesting that hydrogen peroxide, at least in part, evokes neuronal cell death in this model. 6-Hydroxydopamine does not initiate toxicity by dopamine transporter-mediated uptake into PC12 cells, because both GBR-12909 and nisoxetine (inhibitors of dopamine and noradrenaline transporters, respectively) failed to reduce toxicity. 6-Hydroxydopamine has previously been shown to induce both apoptotic and necrotic cell-death mechanisms. In this study oxidative stress initiated by 6-hydroxydopamine caused mitochondrial dysfunction, activation of caspases 3/7, nuclear fragmentation, and apoptosis. We have shown that, in this model, proteolytic activation of the proapoptotic protein kinase C{delta} (PKC{delta}) is a key mediator of 6-hydroxydopamine-induced cell death. 6-Hydroxydopamine induces caspase 3-dependent cleavage of full-length PKC{delta} (79 kDa) to yield a catalytic fragment (41 kDa). Inhibition of PKC{delta} (with rottlerin or via RNA interference-mediated gene suppression) ameliorates the neurotoxicity evoked by 6-hydroxydopamine, implicating this kinase in 6-hydroxydopamine-induced neurotoxicity and Parkinsonian neurodegeneration.


Received for publication, October 25, 2005 , and in revised form, December 15, 2005.

* This work was supported by a Biological and Biotechnological Sciences Research Council Cooperative Award in Science and Engineering Studentship in conjunction with Eli Lilly & Co. (to K. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 To whom correspondence should be addressed: Tel.: 44-1225-385-870; Fax: 44-1225-386-779; E-mail: S.Wonnacott{at}bath.ac.uk.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Evid Based Complement Alternat MedHome page
Y.-T. Shih, I.-J. Chen, Y.-C. Wu, and Y.-C. Lo
San-Huang-Xie-Xin-Tang Protects Against Activated Microglia- and 6-OHDA-induced Toxicity in Neuronal SH-SY5Y Cells
Evid. Based Complement. Altern. Med., April 1, 2009; (2009) nep025v1.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Liu, N. Yamada, W. Maruyama, and T. Osawa
Formation of Dopamine Adducts Derived from Brain Polyunsaturated Fatty Acids: MECHANISM FOR PARKINSON DISEASE
J. Biol. Chem., December 12, 2008; 283(50): 34887 - 34895.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. Pan, G. Wang, H.-Q. Yang, Z. Hong, Q. Xiao, R.-J. Ren, H.-Y. Zhou, L. Bai, and S.-D. Chen
K252a Prevents Nigral Dopaminergic Cell Death Induced by 6-Hydroxydopamine through Inhibition of Both Mixed-Lineage Kinase 3/c-Jun NH2-Terminal Kinase 3 (JNK3) and Apoptosis-Inducing Kinase 1/JNK3 Signaling Pathways
Mol. Pharmacol., December 1, 2007; 72(6): 1607 - 1618.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
C. Iaccarino, C. Crosio, C. Vitale, G. Sanna, M. T. Carri, and P. Barone
Apoptotic mechanisms in mutant LRRK2-mediated cell death
Hum. Mol. Genet., June 1, 2007; 16(11): 1319 - 1326.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement